Researchers in Oregon have engineered a material that replicates human bone tissue with an unprecedented level of precision, from its microscopic crystal structure to its biological activity. They...
A new survey from the OHSU Knight Cancer Institute aims to help researchers understand the cancer-related needs of Oregonians and inform ways to address those needs across the state. Figure:...
The Cascadia Data Discovery Initiative intends to make it easier for cancer researchers to work with each other's data and analytical tools. Microsoft, a technology giant now worth more than $1...
OHSU Knight Cancer Institute scientists have identified key gene networks and signaling pathways that cancerous cells in acute myeloid leukemia use to resist treatment with the drug venetoclax, one...
“The United States represents only five percent of the world’s population and we draw the best minds from all of the world," said Joe Gray, Ph.D. "So, what we don’t want to do is diminish our...
The Early Detection of Cancer Conference is part of a long-term commitment to invest in early detection, to understand the biology behind early stage cancers, find new detection and screening...
Knight Cancer clinicians at Tuality/OHSU Cancer Center are the first in Oregon to offer a treatment option that will improve outcomes for patients with bladder cancer who cannot tolerate surgery or...
Cell fusion is one of the ways that tumors can gain abilities to become life-threatening and resist treatment, Melissa Wong, Ph.D., and colleagues first reported last year. The paper now is one of...
Knight Cancer researchers describe positive results with the drug regorafenib. Osteosarcoma is a bone cancer that disproportionately affects teenagers, and despite substantial efforts, outcomes for...
Cancer clinical trials that use less-reliable shortcut endpoints save relatively little time, according to an analysis of 107 cancer drugs approved for 188 indications from 2006 to 2017. Image:...